Schedule 13G ownership disclosure
BIONTECH SE
Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) · CUSIP: 09075V102
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Medine GmbH
Shares: 40,127,697.00 · Class: 16.7%
- Prof. Ugur Sahin, M.D.
Shares: 42,178,034.00 · Class: 17.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002056296-25-000003
- Form type
- SCHEDULE 13G/A
- Filer
- BioNTech SE
- CIK
- CIK 1776985
- Filed
- May 13, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership